BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34489549)

  • 1. FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway.
    Feng H; Jin Z; Liang J; Zhao Q; Zhan L; Yang Z; Yan J; Kuang J; Cheng X; Qiu W
    Oncogene; 2021 Oct; 40(42):6115-6129. PubMed ID: 34489549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 6. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
    Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages.
    Lisi L; Pia Ciotti GM; Chiavari M; Ruffini F; Lacal PM; Graziani G; Navarra P
    Oncol Rep; 2020 Jun; 43(6):2083-2092. PubMed ID: 32236632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
    Cao X; Dang L; Zheng X; Lu Y; Lu Y; Ji R; Zhang T; Ruan X; Zhi J; Hou X; Yi X; Li MJ; Gu T; Gao M; Zhang L; Chen Y
    Thyroid; 2019 Jun; 29(6):809-823. PubMed ID: 30924726
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression and localization of vascular endothelial growth factor A (VEGFA) and its two receptors (VEGFR1/FLT1 and VEGFR2/FLK1/KDR) in the canine corpus luteum and utero-placental compartments during pregnancy and at normal and induced parturition.
    Gram A; Hoffmann B; Boos A; Kowalewski MP
    Gen Comp Endocrinol; 2015 Nov; 223():54-65. PubMed ID: 26414127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.
    Zhang L; Lv Z; Xu J; Chen C; Ge Q; Li P; Wei D; Wu Z; Sun X
    FEBS J; 2018 Apr; 285(7):1359-1371. PubMed ID: 29474747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
    Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
    Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
    Bieche I; Vacher S; Vallerand D; Richon S; Hatem R; De Plater L; Dahmani A; Némati F; Angevin E; Marangoni E; Roman-Roman S; Decaudin D; Dangles-Marie V
    BMC Cancer; 2014 Mar; 14():178. PubMed ID: 24625025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
    Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
    Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
    Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
    Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W
    Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
    Wang XM; Liu Y; Fan YX; Liu Z; Yuan QL; Jia M; Geng ZS; Gu L; Lu XB
    Cancer Biol Ther; 2018 Jul; 19(7):590-597. PubMed ID: 29561707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
    Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
    J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.